Dong, Li
Li, Yi Fan
Wu, Hao Tian
Di Kou, Hai
Lan, Yin Jun
Wang, Ya Xing
Jonas, Jost B.
Wei, Wen Bin
Funding for this research was provided by:
National Natural Science Foundation of China (81570891)
Article History
Received: 29 April 2020
Accepted: 14 August 2020
First Online: 25 August 2020
Ethics approval and consent to participate
: The Ethics Committee of the Beijing Tongren Hospital study approved the study, and the ARVO Statement for the use of animals in ophthalmic and vision research was taken into account.
: Not applicable.
: Jost B. Jonas: Patent application with University of Heidelberg (Heidelberg, Germany) (Title: Agents for use in the therapeutic or prophylactic treatment of myopia or hyperopia; European Patent Number: 3 070 101).